Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Molecular Biology

• Publication date

  1998-09-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/JMBI.1998.1977PMID 9719643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiangiogenic and antiproliferative activity of suramin analogues

  1997cited by this paper
• Discovering High-Affinity Ligands for Proteins

  1997cited by this paper
• Cell Release of Bioactive Fibroblast Growth Factor 2 by Exon 6-encoded Sequence of Vascular Endothelial Growth Factor*

  1997cited by this paper
• Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo

  1997cited by this paper
• Antiangiogenic naphthalene sulfonic distamycin-A derivatives tightly interact with human basic fibroblast growth factor

  1997cited by this paper
• Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

  1997cited by this paper
• Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.

  1997cited by this paper
• Angiogenesis in colorectal cancer.

  1997cited by this paper
• Of Worms and Men: An Evolutionary Perspective on the Fibroblast Growth Factor (FGF) and FGF Receptor Families

  1997cited by this paper
• Destabilization, oligomerization and inhibition of the mitogenic activity of acidic fibroblast-growth factor by aurintricarboxylic acid.

  1997cited by this paper
• Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.

  1997cited by this paper
• Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes

  1997cited by this paper
• Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog.

  1996cited by this paper
• X-ray structure of native full-length human fibroblast-growth factor at 0.25-nm resolution.

  1996cited by this paper
• Angiogenesis and metastasis.

  1996cited by this paper
• Fibroblast growth factors

  1996cited by this paper
• Inhibitors of angiogenesis in a clinical perspective.

  1996cited by this paper
• Heparin Structure and Interactions with Basic Fibroblast Growth Factor

  1996cited by this paper
• Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Probing the molten globule state of alpha-lactalbumin by limited proteolysis.

  1995cited by this paper
• New sulfonated distamycin A derivatives with bFGF complexing activity.

  1994cited by this paper
• Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.

  1994cited by this paper
• Effect of low pH and heparin on the structure of acidic fibroblast growth factor.

  1994cited by this paper
• Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding.

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• 1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate.

  1994cited by this paper
• Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis.

  1994cited by this paper
• Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.

  1994cited by this paper
• Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.

  1994cited by this paper
• A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions.

  1994cited by this paper
• Fibroblast growth factors, proteins with a broad spectrum of biological activities.

  1994cited by this paper
• Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.

  1994cited by this paper
• Detection, delineation, measurement and display of cavities in macromolecular structures.

  1994cited by this paper
• Physical stabilization of acidic fibroblast growth factor by polyanions.

  1993cited by this paper
• Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.

  1993cited by this paper
• Suramin awakes?

  1992cited by this paper
• beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors.

  1992cited by this paper
• Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.

  1992cited by this paper
• Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

  1992cited by this paper
• In vitro activity of novel sulphonic derivatives of distamycin A.

  1992cited by this paper
• Inhibition of angiogenesis by suramin.

  1992cited by this paper
• In vivo activity of novel sulphonic derivatives of distamycin A.

  1992cited by this paper
• Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction.

  1992cited by this paper
• Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer.

  1992cited by this paper
• Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions

  1992cited by this paper
• Nature of the interaction of growth factors with suramin.

  1992cited by this paper
• High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions.

  1992cited by this paper
• β-Trefoil fold: Patterns of structure and sequence in the Kunitz inhibitors interleukins-1β and 1α and fibroblast growth factors

  1992cited by this paper
• Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA.

  1991cited by this paper
• Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

  1991cited by this paper
• Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

  1991cited by this paper
• Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints

  1991cited by this paper
• The structure of human acidic fibroblast growth factor and its interaction with heparin.

  1991cited by this paper
• Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor.

  1991cited by this paper
• Peptide Growth Factors and Their Receptors I

  1990cited by this paper
• Structural features of neutral protease from Bacillus subtilis deduced from model-building and limited proteolysis experiments.

  1990cited by this paper
• Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.

  1990cited by this paper
• Pharmacokinetics and Distribution of Heparin‐Binding Growth Factor I (Endothelial Cell Growth Factor) in the Rat

  1989cited by this paper
• The heparin-binding (fibroblast) growth factor family of proteins.

  1989cited by this paper
• NMR of proteins and nucleic acids

  1988cited by this paper
• Angiogenic factors.

  1987cited by this paper
• An in vivo model for study of the angiogenic effects of basic fibroblast growth factor.

  1987cited by this paper
• Correlation between sites of limited proteolysis and segmental mobility in thermolysin.

  1986cited by this paper
• Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities.

  1986cited by this paper
• Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1.

  1985cited by this paper
• MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy

  1985cited by this paper
• Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

  1985cited by this paper
• Practical aspects of two-dimensional transverse NOE spectroscopy

  1985cited by this paper
• Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances.

  1984cited by this paper
• Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins.

  1983cited by this paper
• A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

  1980cited by this paper
• Two‐dimensional spectroscopy. Application to nuclear magnetic resonance

  1976cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• Synthesis of Novel Suramin Analogs With Anti-Proliferative Activity via FGF1 and FGFRD2 Blockade

  2022cites this paper
• Suramin derivatives play an important role in blocking the interaction between FGF1 and FGFRD2 to inhibit cell proliferation.

  2020cites this paper
• Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.

  2020cites this paper
• 100 years of suramin

  2019cites this paper
• Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends

  2019cites this paper
• 100 Years of Suramin

  2019cites this paper
• Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.

  2017cites this paper
• Ischemic optic neuropathy as a model of neurodegenerative disorder: A review of pathogenic mechanism of axonal degeneration and the role of neuroprotection.

  2017cites this paper
• Medical Devices and Preparative Medicine: Polymer Drug Application

  2017cites this paper
• Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors

  2016cites this paper
• Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165.

  2015cites this paper
• Application of polymer drugs to medical devices and reparative medicine

  2013cites this paper
• Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.

  2013cites this paper
• Heparin-Like Drugs with Antiangiogenic Activity

  2012cites this paper
• Treatment of Infiltrative Basal Cell Carcinomas by inhibiting the Fibroblast Growth Factor (FGF)-Signal Transducer and Activator of Transcription (STAT)-3 Signalling Pathways

  2012cites this paper
• WITHDRAWN: Interaction of FGF1 with a novel anti-angiogenic drug SSR128129E.

  2012cites this paper
• NF449 Is a Novel Inhibitor of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling Active in Chondrocytes and Multiple Myeloma Cells*

  2010cites this paper
• Gentisic Acid, a Compound Associated with Plant Defense and a Metabolite of Aspirin, Heads a New Class of in Vivo Fibroblast Growth Factor Inhibitors*

  2010cites this paper
• Molecular level interaction of the human acidic fibroblast growth factor with the antiangiogenic agent, inositol hexaphosphate .

  2010cites this paper
• A new model for mapping the peptide backbone: predicting proton chemical shifts in proteins.

  2010cites this paper
• Antimitogenic polymer drugs based on AMPS: monomer distribution-bioactivity relationship of water-soluble macromolecules.

  2010cites this paper
• A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

  2009cites this paper
• Una aproximación farmacológica al tratamiento de la acondroplasia

  2008cites this paper
• NMR structural studies of oligosaccharides related to cancer processes.

  2008cites this paper
• Effect of PPADS on achondroplasic chondrocytes: inhibition of FGF receptor type 3 over-activity.

  2008cites this paper
• Suramin: clinical uses and structure-activity relationships.

  2008cites this paper
• Chemistry and biology of heparin mimetics that bind to fibroblast growth factors.

  2007cites this paper
• Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice.

  2007cites this paper
• Understanding the mechanism of the antimitogenic activity of suramin.

  2006cites this paper
• Dobesilate diminishes activation of the mitogen - activated protein kinase ERK1/2 in glioma cells

  2006cites this paper
• Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein.

  2005cites this paper
• Interactions of charged ligands with beta(2)-microglobulin conformers in affinity capillary electrophoresis.

  2005cites this paper
• Dihydroxy-2,5 benzenesulphonate (dobesilate) elicits growth arrest and apoptosis in glioma cells

  2005cites this paper
• An Experimental and Molecular‐Modeling Study of the Binding of Linked Sulfated Tetracyclitols to FGF‐1 and FGF‐2

  2005cites this paper
• Validation of molecular docking calculations involving FGF-1 and FGF-2.

  2004cites this paper
• Fibroblast growth factor 1: a key regulator of human adipogenesis.

  2004cites this paper
• Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.

  2004cites this paper
• Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a "protein misfolding disease".

  2004cites this paper
• Targeted Therapy of Endometrial Cancer

  2004cites this paper
• Inhibition of angiogenesis at endothelial cell level

  2003cites this paper
• Leads for Development of New Naphthalenesulfonate Derivatives with Enhanced Antiangiogenic Activity

  2003cites this paper
• Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding.

  2002influential citation
• Capillary electrophoresis investigation of a partially unfolded conformation of β2‐microglobulin

  2002cites this paper
• Suramin affects coupling of rhodopsin to transducin.

  2002cites this paper
• Solution Structure and Interaction with Basic and Acidic Fibroblast Growth Factor of a 3-kDa Human Platelet Factor-4 Fragment with Antiangiogenic Activity* 210

  2001cites this paper
• Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.

  2001cites this paper
• Oncogenic Ras-Induced Proliferation Requires Autocrine Fibroblast Growth Factor 2 Signaling in Skeletal Muscle Cells

  2001cites this paper
• The Activation of Fibroblast Growth Factors by Heparin: Synthesis, Structure, and Biological Activity of Heparin‐Like Oligosaccharides

  2001cites this paper
• Abolished angiogenicity and tumorigenicity of rat glioma by 1-naphthalenemonosulfonate.

  2001cites this paper
• Tumor angiogenesis as a therapeutic target.

  2001cites this paper
• Fibroblast growth factors and their inhibitors.

  2000cites this paper
• 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor.

  2000cites this paper
• Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

  2000cites this paper
• Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily

  2000cites this paper
• Energetics of myo-inositol hexasulfate binding to human acidic fibroblast growth factor effect of ionic strength and temperature.

  2000cites this paper
• Apoptosis of glioma cells induced by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate.

  1999cites this paper
• Inhibition of intra-tumoral angiogenesis and glioma growth by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate.

  1999cites this paper
• Suppression of acidic fibroblast growth factor-dependent angiogenesis by the antigrowth activity of 1,3,6-naphthalenetrisulfonate.

  1999cites this paper